The physiological role of regulatory T cells in the prevention of autoimmunity: Generation, specificity and mode of action

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 5, 2000, Pages 339-345

  Seddon, Benedict ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

Autoimmunity; Prevention; Regulatory T cells

Indexed keywords

ANIMAL; AUTOIMMUNITY; BIOLOGICAL MODEL; IMMUNOLOGY; PHYSIOLOGY; RAT; REVIEW; T LYMPHOCYTE SUBPOPULATION; THYMUS;

ANIMALS; AUTOIMMUNITY; MODELS, IMMUNOLOGICAL; RATS; T-LYMPHOCYTE SUBSETS; THYMUS GLAND;

EID: 0034566984     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. ANTONIA S. J., GEIGER T., MILLER J. and FLAVELL R. A. (1995): Mechanisms of immune tolerance induction through the thymic expression of a peripheral tissue-specific protein. Int Immunol., 7, 715-725.
2. ARTHUR R. P. and MASON D. (1986): T cells that help B cell responses to soluble antigen are distinguishable from those producing interleukin 2 on mitogenic or allogeneic stimulation. J. Exp. Med., 163, 774-786.
3. BRIDOUX F., BADOU A., SAOUDI A., BERNARD I., DRUET E., PASQUIER R., DRUET P. and PELLETIER L. (1997): Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J. Exp. Med., 185, 1769-1775.
4. CRISA L., MORDES J. P. and ROSSINI A. A. (1992): Autoimmune diabetes mellitus in the BB rat. Diabetes Metab. Rev., 8, 4-37.
5. EISHI Y. and MCCULLAGH P. (1988): Acquisition of immunological self-recognition by the fetal rat. Immunology, 64, 319-323.
6. EISHI Y. and MCCULLAGH P. (1988): PVG rats, resistant to experimental allergic thyroiditis, develop high serum levels of thyroglobulin after sensitization. Clin. Immunol. Immunopathol., 49, 101-106.
7. FOWELL D. and MASON D. (1993): Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J. Exp. Med., 177, 627-636.
8. GROUX H. and POWRIE F. (1999): Regulatory T cells and inflammatory bowel disease. Immunol. Today, 20, 442-445.
9. HAN H. S., JUN H. S., UTSUGI T. and YOON J. W. (1996): A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice. J. Autoimmun., 9, 331-339.
10. HEATH V. L., MOORE N. C., PARNELL S. M. and MASON D. W. (1998): Intrathymic expression of genes involved in organ specific autoimmune disease. J. Autoimmun., 11, 309-318.
11. INOBE J. I., CHEN Y. and WEINER H. L. (1996): In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci., 778, 390-392.
12. INOBE J., SLAVIN A. J., KOMAGATA Y., CHEN Y., LIU L. and WEINER H. L. (1998): IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol., 28, 2780-2790.
13. KAPPLER J. W., ROEHM M. and MARRACK P. (1987): T cell tolerance by clonal elimination in the thymus. Cell, 49, 273-280.
14. KULKARNI A. B., HUH C. G., BECKER D., GEISER A., LYGHT M., FLANDERS K. C., ROBERTS A. B., SPORN M. B., WARD J. M. and KARLSSON S. (1993): Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA, 90, 770-774.
15. LE DOUARIN N., CORBEL C., BANDEIRA A., THOMAS-VASLIN V., MODIGLIANI Y., COUTINHO A. and SALAÜN J. (1996): Evidence for a thymus-dependent form of tolerance that is not based on elimination or anergy of reactive T cells. Immunol. Rev., 149, 35-54.
16. MCCULLAGH P. (1990): Curtailment of autoimmunity following parabiosis with a normal partner. Immunology, 71, 595-597.
17. + T cells. Eur. J. Immunol., 21, 1187-1194.
18. MILLER A., LIDER O., ROBERTS A. B., SPORN M. B. and WEINER H. L. (1992): Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. USA, 89, 421-425.
19. MORAHAN G., ALLISON J. and MILLER J. F. (1989): Tolerance of class I histocompatibility antigens expressed extrathymically. Nature, 339, 622-624.
20. MUELLER D. L., JENKINS M. K. and SCHWARTZ R. H. (1989): Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol., 7, 445-480.
21. MUELLER R., KRAHL T. and SARVETNICK N. (1996): Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med., 184, 1093-1099.
22. NICKOLOFF B. J. and TURKA L. A. (1994): Immunological functions of non-professional antigen-presenting cells: new in-sights from studies of T-cell interactions with keratinocytes. Immunol. Today, 15, 464-469.
23. OHASHI P. S., OEHEN S., BUERKI K., PIRCHER H., OHASHI C. T., ODERMATT B., MALISSEN B., ZINKERNAGEL R. M. and HENGARTNER H. (1991): Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell., 65, 305-317.
24. PENHALE W. J., FARMER A. and IRVINE W. J. (1975): Thyroiditis in T cell-depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum. Clin. Exp. Immunol., 21, 362-375.
25. PENHALE W. J., FARMER A., MCKENNA R. P. and IRVINE W. J. (1973): Spontaneous thyroiditis in thymectomized and irradiated Wistar rats. Clin. Exp. Immunol., 15, 225-236.
26. PENHALE W. J., IRVINE W. J., INGLIS J. R. and FARMER A. (1976): Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by reconstitution with normal lymphoid cells. Clin. Exp. Immunol., 25, 6-16.
27. POWRIE F., CARLINO J., LEACH M. W., MAUZE S. and COFFMAN R. L. (1996): A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB low CD4+ T cells. J. Exp. Med., 183, 2669-2674.
28. POWRIE F. and MASON D. (1989): The MRC OX-22-CD4+ T cells that help B cells in secondary immune responses derive from naive precursors with the MRC OX-22+ CD4+ phenotype. J. Exp. Med., 169, 653-662.
29. POWRIE F. and MASON D. (1990): OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset (published erratum appears in J. Exp. Med. 1991 Apr 1;173(4), 1037). J. Exp. Med., 172, 1701-1708.
30. RAPOPORT M. J., JARAMILLO A., ZIPRIS D., LAZARUS A. H., SERREZE D. V., LEITER E. H., CYOPICK P., DANSKA J. S. and DELOVITCH T. L. (1993): Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice. J. Exp. Med., 178, 87-99.
31. RIA F., PENNA G. and ADORINI L. (1998): Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells. Eur. J. Immunol., 28, 2003-2016.
32. SAKAGUCHI S., TAKAHASHI T. and NISHIZUKA Y. (1982): Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirements of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med., 156, 1577-1586.
33. SAOUDI A., SEDDON B., FOWELL D. and MASON D. (1996): The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into pre-diabetic recipients. J. Exp. Med., 184, 2393-2398.
34. SAOUDI A., SEDDON B., HEATH V., FOWELL V. and MASON D. (1996): The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset Immunol. Rev., 149, 195-216.
35. SEDDON B. and MASON D. (1999): Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med., 189, 877-881.
36. SEDDON B. and MASON D. (1999): Regulatory T cells in the control of autoimmunity: the essential role of TGF-β and IL-4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4+CD45RC-cells and CD4+CD8-thymocytes. J. Exp. Med., 189, 279-288.
37. SEDDON B., SAOUDI A., NICHOLSON M. and MASON D. (1996): CD4+CD8-thymocytes that express L-Selectin protect rats from diabetes upon adoptive transfer. Eur. J. Immunol., 26, 2702-2708.
38. SEDER R. A., Marth T., SIEVE M. C., STROBER W., LETTERIO J. J., ROBERTS A. B. and KELSALL B. (1998): Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J. Immunol., 160, 5719-5728.
39. SHULL M. M., ORMSBY I., KIER A. B., PAWLOWSKI S., DIEBOLD R. J., YIN M., ALLEN R., SIDMAN C., PROETZEL G., CALVIN D., ANNUNZIATA N. and DOETSCHMAN T. (1992): Targeted disrup-tion of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature, 359, 693-699.
40. WEINER H. L., FRIEDMAN A., MILLER A., KHOURY S. J., ALSABBAGH A., SANTOS L., SAYEGH M., NUSSENBLATT R. B., TRENTHAM D. E. and HAFLER D. A. (1994): Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol., 12, 809-837.